Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study

DE Bonds, JC Larson, AV Schwartz… - The Journal of …, 2006 - academic.oup.com
Context: Some but not all studies have shown higher rates of fracture in individuals with
type 2 diabetes. Objective: The objective of the study was to determine the risk of fracture in …

Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative

…, BV Howard, B Kestenbaum, JC Larson… - Diabetes …, 2008 - Am Diabetes Assoc
OBJECTIVE—Experimental and epidemiologic studies suggest that calcium and vitamin D
may reduce the risk of developing diabetes. We examined the effect of calcium plus vitamin D …

Mortality and cardiac and vascular outcomes in extremely obese women

K McTigue, JC Larson, A Valoski, G Burke, J Kotchen… - Jama, 2006 - jamanetwork.com
ContextObesity, typically measured as body mass index of 30 or higher, has 3 subclasses:
obesity 1 (30-34.9); obesity 2 (35-39.9); and extreme obesity (≥40). Extreme obesity is …

Effect of estrogen therapy on gallbladder disease

…, P Greenland, AZ LaCroix, MC Limacher, JC Larson - Jama, 2005 - jamanetwork.com
ContextEstrogen therapy is thought to promote gallstone formation and cholecystitis but most
data derive from observational studies rather than randomized trials.ObjectiveTo determine …

Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial

…, H Joffe, JS Carpenter, GL Anderson, JC Larson… - Jama, 2011 - jamanetwork.com
Context Concerns regarding the risks associated with estrogen and progesterone to
manage menopausal symptoms have resulted in its declining use and increased interest in …

Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study

…, C Allen, A Assaf, BB Cochrane, JC Larson… - Circulation, 2005 - Am Heart Assoc
Background— Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in
women and may vary by hysterectomy (or oophorectomy) status. This study compared CVD …

Symptom experience after discontinuing use of estrogen plus progestin

JK Ockene, DH Barad, BB Cochrane, JC Larson… - Jama, 2005 - jamanetwork.com
ContextLittle is known about women’s experiences after stopping menopausal hormone
therapy.ObjectiveTo describe women’s symptoms and management strategies after stopping …

[HTML][HTML] Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study

TS Orchard, JC Larson, N Alghothani… - The American journal of …, 2014 - Elsevier
Background: Magnesium is a necessary component of bone, but its relation to osteoporotic
fractures is unclear. Objective: We examined magnesium intake as a risk factor for …

Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative

PM Rautaharju, C Kooperberg, JC Larson, A LaCroix - Circulation, 2006 - Am Heart Assoc
Background— Information is limited about the independent prognostic value of repolarization
abnormalities in women. Methods and Results— We evaluated hazard ratios for ECG …

Efficacy of exercise for menopausal symptoms: a randomized controlled trial

…, KA Guthrie, KE Ensrud, AZ LaCroix, JC Larson… - Menopause, 2014 - journals.lww.com
Objective This study aims to determine the efficacy of exercise training for alleviating vasomotor
and other menopausal symptoms. Methods Late perimenopausal and postmenopausal …